US Tightens AI Chip Export Rules, Impacting Nvidia and AMD Sales to Chinese Firms 
TSMC Sees Strong AI-Driven Growth as Demand for Advanced Chips Continues to Surge 
Morgan Stanley Upgrades Winbond and Nanya to Overweight on Strong Memory Chip Market Outlook 
South Korea Weighs AI Profit Sharing as Samsung and SK Hynix Earnings Surge 
Anthropic Files for IPO, Signaling a New Era for Public AI Investments in 2026 
SpaceX Sets IPO Price at $135 Per Share Ahead of Historic Nasdaq Debut 
Qualcomm Stock Gains After Jensen Huang Endorsement 
HPE Raises 2026 Outlook After Record Q2 Revenue Fueled by AI Server Demand 
US Officials Explore AI Company Equity Stakes Ahead of OpenAI and Anthropic IPO Plans 
Meta Delays Release of New AI Model as API Rollout Remains Uncertain 
Switch Eyes Multi-Billion-Dollar Funding Round at $50 Billion Valuation Ahead of Potential IPO 
Hyundai, Nvidia, and South Korea Near Deal for Major AI Technology Center 
Meta Challenges Australia’s Proposed Tech Tax, Citing U.S. Trade Agreement Concerns 
DeepSeek Targets $7.4 Billion Funding Round, Valuation Could Reach $59 Billion in 2026 
Alphabet Unveils $80 Billion Capital Raise to Accelerate AI Expansion, Secures $10 Billion Backing from Berkshire Hathaway 
Jensen Huang Strengthens Nvidia’s South Korea Ties Amid AI Expansion 
Nvidia Unveils RTX Spark AI PC Chips, Expands Challenge to Intel, AMD, and Apple 
The Apple Watch is expected to feature important health monitoring features that could provide blood pressure and blood sugar information. However, a new report says its development has faced some issues, and they are not expected to become available in the next few years.
Every year, in anticipation of a new Apple Watch, advanced health monitoring features are commonly mentioned in reports. But Bloomberg's Mark Gurman reports that the smartwatch's capability to track blood pressure is unlikely to launch until 2024 "at the earliest."
Sources of Gurman said the development of the blood pressure monitoring for the Apple Watch has faced some issues with accuracy during testing that led to its delay. While its launch is possible in the next two years, the same report said the timeframe could still extend to 2025.
Apple is said to be testing the Apple Watch blood pressure monitor on its employees, and its implementation could be different from Samsung's blood pressure detection. Newer Galaxy Watch models provide specific systolic and diastolic readings, but users need to calibrate the device every four weeks by manually entering blood pressure readings after using a conventional monitoring cuff. Apple's version is not expected to provide specific readings, but the report says future Apple Watches may issue warnings if the user potentially has hypertension and if they need to consult a doctor.
Meanwhile, Apple Watch fans might have to wait longer for the non-invasive blood sugar monitoring function. Gurman said this health feature does not even have a release timeline yet, but it is "still several years away" from launch.
Apple, however, is still expected to introduce new health features sooner, including the body temperature sensor that could launch with the 2022 Apple Watch. Its first version is expected to focus on fertility and family planning, but the report said its use could be expanded to let users know if their body temperature is higher than normal.
The report also mentioned an anticipated improvement in the Apple Watch's low-power mode through watchOS 9. The update could allow users to access more apps and features even when they enable the Power Reserve setting. watchOS 9 will be one of the main announcements in the upcoming WWDC that will kick off on June 6.
Photo by Onur Binay on Unsplash
